A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

Clinical trial NCT06694935 · RECRUITING

Trial details

NCT number: NCT06694935
Sponsor: 1Globe Health Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Non-Alcoholic Fatty Liver Disease (NAFLD)

Start date: 2025-01-06
Primary completion: 2025-07-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.